Matinas BioPharma updates corporate presentation; no specific disclosures

Matinas BioPharma Holdings, Inc.

Filed an updated corporate presentation dated January 9, 2024, for use at conferences and investor meetings.
No financial results, pipeline updates, or material agreements were disclosed in the filing.
The presentation is attached as Exhibit 99.1 but its content is not summarized in the 8-K.
Ticker: MTNB (NYSE American). Event is a routine Regulation FD disclosure.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.